Search

everythinglearnresearchcommunity

for

Search:↓

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Blocking neurosteroid production can lead to more seizures and faster epilepsy onset in rats.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

RNase L hinders hair follicle regeneration by altering immune signals.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

Special cells can help regrow hair in alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

Stress increases nerve growth factor, causing hair loss in mice.